AKBA
Akebia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.92
+2.26%0
Insider buys (3m)
1
Insider sells (3m)
-$62.2K
Net value (3m)
-17.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | Butler John P. · director, officer: CEO and President | M-Exempt | 350,000 | $0.63 |
| Jul 1, 2026 | Ostrowski Erik · officer: SVP, CFO, CBO & Treasurer | Sale | 56,019 | $1.11 |
| Jun 22, 2026 | ROGERS MICHAEL W · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | FRIESON RON · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | Wolf Myles · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ZUMWALT LEANNE M · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | ZUMWALT LEANNE M · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ADAMS ADRIAN · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | Smith Cynthia · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ROGERS MICHAEL W · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | ADAMS ADRIAN · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | FRIESON RON · director | A-Award | 53,600 | $1.02 |
| Jun 22, 2026 | Wolf Myles · director | A-Award | 35,700 | $0.00 |
| Jun 22, 2026 | Smith Cynthia · director | A-Award | 35,700 | $0.00 |
| Apr 3, 2026 | Vickers Philip J. · director | A-Award | 214,400 | $1.41 |
| Mar 5, 2026 | Butler John P. · director, officer: CEO and President | Purchase | 69,270 | $1.25 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | Sale | 96,065 | $1.39 |
| Feb 4, 2026 | Burke Steven Keith · officer: SVP, Chief Medical Officer | Sale | 25,375 | $1.39 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | A-Award | 175,250 | $1.41 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | Sale | 46,660 | $1.39 |
| Feb 4, 2026 | Burke Steven Keith · officer: SVP, Chief Medical Officer | Sale | 21,582 | $1.39 |
| Feb 4, 2026 | Malabre Richard C · officer: SVP, Chief Accounting Officer | Sale | 13,382 | $1.39 |
| Feb 4, 2026 | Grund Nicholas · officer: Chief Commercial Officer | Sale | 53,585 | $1.39 |
| Feb 4, 2026 | Rucci Carolyn M. · officer: SVP, Chief Legal Officer | Sale | 27,544 | $1.39 |
| Feb 4, 2026 | Grund Nicholas · officer: Chief Commercial Officer | Sale | 31,244 | $1.39 |
| Feb 4, 2026 | Rucci Carolyn M. · officer: SVP, Chief Legal Officer | Sale | 25,382 | $1.39 |
| Feb 4, 2026 | Malabre Richard C · officer: SVP, Chief Accounting Officer | Sale | 36,142 | $1.39 |
| Feb 4, 2026 | Ostrowski Erik · officer: SVP, CFO, CBO & Treasurer | Sale | 34,951 | $1.39 |
| Feb 4, 2026 | Rucci Carolyn M. · officer: SVP, Chief Legal Officer | Sale | 16,846 | $1.39 |
| Feb 4, 2026 | Butler John P. · director, officer: CEO and President | Sale | 114,891 | $1.39 |
Institutional positioning
13F filings over the trailing two quarters
New 74Increased 109Reduced 92Sold out 36
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 19,986,374 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 18,693,296 | May 13, 2026 |
| STATE STREET CORP | Reduced | 11,614,006 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 11,322,143 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 11,166,710 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 9,151,524 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,727,302 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,452,252 | May 15, 2026 |
| STATE STREET CORP | Reduced | 5,390,853 | Aug 7, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4,706,437 | Mar 25, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Increased | 4,273,026 | Aug 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 4,004,867 | Aug 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 3,689,167 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 3,602,827 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,196,605 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026